Discovery and structure-activity relationship of novel 4-hydroxythiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators
Discovery and structure-activity relationship of novel 4-hydroxythiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators
复制标题
作为肿瘤细胞特异性丙酮酸激酶 M2 激活剂的新型 4-羟基噻唑烷-2-硫酮衍生物的发现及其构效关系
DOI:
10.1016/j.ejmech.2017.11.023
复制
发表时间:
2017
影响因子:
6.7
通讯作者:
Yuxin Yin
中科院分区:
文献类型:
--
作者:
Ridong Li;Xianling Ning;Shuo Zhou;Zhiqiang Lin;Xingyu Wu;Hong Chen;Xinyu Bai;Xin Wang;Zemei Ge;Runtao Li;Yuxin Yin
Pyruvate kinase M2 isoform (PKM2) is a crucial protein responsible for aerobic glycolysis of cancer cells. Activation of PKM2 may alter aberrant metabolism in cancer cells. In this study, we discovered a 4-hydroxy-thiazolidine-2-thione compound2as a novel PKM2 activator from a random screening of an in-house compound library. Then a series of novel 4-hydroxy-thiazolidine-2-thione derivatives were designed and synthesized for screening as potent PKM2 activators. Among these, some compounds showed higher PKM2 activation activity than lead compound2and also exhibited significant anti-proliferative activities on human cancer cell lines at nanomolar concentration. The compound5wwas identified as the most potent antitumor agent, which showed excellent anti-proliferative effects with IC50values from 0.46 μM to 0.81 μM against H1299, HCT116, Hela and PC3 cell lines.5walso showed less cytotoxicity in non-tumor cell line HELF compared with cancer cells. In addition, Preliminary pharmacological studies revealed that5warrests the cell cycle at the G2/M phase in HCT116 cell line. The best PKM2 activation by compound5twas rationalized through docking studies.